Novartis is developing an experimental drug for weight loss.

Novel PRC2 inhibitor changes the expression of hundreds of genes in lab model

How Shannon Campbell, Senior Vice President & Franchise Head at Novartis Oncology, came into her current role and leadership position.

We leave the lab to find out what people know about cell and gene therapy.

Make smart decisions about your research projects.

A global survey revealed major disconnects in communication, disease awareness and expectations between patients and physicians.

Read a patient’s perspective on living with a rare, life-threatening blood cancer called myelofibrosis and why it’s important to rally the community.

Novartis researchers are collaborating with tech startup PathAI to search for hidden information in pathology slides.

Novartis is investing in a novel type of medicine to reduce the risk of heart disease.